510(k) Report

510(k) · Cleared

Cleared

A/C Enzymatic Vitamin B6 Assay

K111260510(k) TraditionalCleared Jul 26, 2012448-day reviewClass II21 CFR 862.1810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Anticancer, Inc. · CDD Radioassay, Vitamin B12

Cleared on Jul 26, 2012 as substantially equivalent to K955561 (American Laboratory Products Co., Ltd., 1996) after a 448-day review. Its family tree reaches back 1 generation to 1996.

Decided
Jul 26, 2012
Review
448 days
Class
Class II
Product code
CDD
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K955561 (1996). No later device cites it as a predicate yet.

K955561 · Buhlmann Vitamin B6 Rea · American Laboratory Products Co., Ltd. · 19961995200020052010
  1. Root · 1 generation backK955561 Buhlmann Vitamin B6 ReaAmerican Laboratory Products Co., Ltd. · 1996
  2. This deviceK111260 A/C Enzymatic Vitamin B6 AssayAnticancer, Inc. · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K955561Buhlmann Vitamin B6 ReaAmerican Laboratory Products Co., Ltd.1996—
0 (this device)K111260A/C Enzymatic Vitamin B6 AssayAnticancer, Inc.2012—
FIG. 1 — Lineage of K111260, 1996–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CDD device

  1. #1 K233541 ARCHITECT Active-B12 (Holotranscobalamin)score 8.7 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K955561Buhlmann Vitamin B6 Rea
Summary page 2
…amin B6 REA American Laboratory Products CO., LTD PO BOX 4511 Windham, NH 03087 Tel: (603) 893-8914 (2) Predicate 5 10(k) number K955 561 4. Information of Manufacturer Manufacturer: Bioserv Corporation 5340 Eastgate Mall San D…
American Laboratory Products Co., Ltd.1996—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All CDD devices

CDD Radioassay, Vitamin B12: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · CDD

1in 2024

2007: 12009: 12010: 12011: 32012: 32013: 12014: 22015: 12016: 22017: 12019: 22022: 12024: 1
2007high 3 (2011) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CDD

147in 2012

2011: 117 days median2012: 147 days median
2007high 147 (2012) · low 117 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CDD

1in 2021

2007: 12018: 22019: 12021: 1
2007high 2 (2018) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CDD

44in 2025

2010: 42011: 362012: 232013: 452014: 122015: 42016: 62017: 92018: 152019: 142020: 112021: 282022: 242023: 272024: 332025: 44
2007high 45 (2013) · low 0 (2007)2025

MAUDE reports naming product code CDD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—10
20080—00
20091—00
20101—04
20113117036
20123147023
20131—045
20142—012
20151—04
20162—06
20171—09
20180—215
20192—114
20200—011
20210—128
20221—024
20230—027
20241—033
20250—044
20260—0—

What is it indicated for?

The A/C Enzymatic Vitamin B6 Assay is intended for the quantitative determination of pyridoxal 5'-phosphate (PLP, vitamin B36) in EDTA-plasma.

The device will monitor vitamin 86 (PLP) status in human plasma for aid in diagnosis of vitamin 86 deficiency.

The A/C Enzymatic Vitamin B6 Assay is for IN VITRO DIAGNOSTIC USE ONLY.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K111260: A/C Enzymatic Vitamin B6 Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K111260

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026